The following members have been appointed to Herantis Pharma's Shareholders' Nomination Committee:
- Kyösti Kakkonen, representing Joensuun Kauppa ja
Kone Oy (Chairman), -
Pia Gisgard, representing
Swedbank Robur , - Timo Syrjälä representing himself and Acme Investments SPF S.à.r.l., and
Timo Veromaa , the Chairman of Herantis Pharma's Board of Directors.
Herantis Pharma's Shareholders' Nomination Committee consists of four members, of which three represent the company's shareholders. The Chairman of Herantis Pharma's Board of Directors will serve as the fourth member of the Nomination Committee.
The Shareholders' Nomination Committee prepares and presents to the Annual General Meeting proposals on the remuneration, number and members of the Board of Directors.
For more information, please contact:
Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19
Email: ir@herantis.com
-----------
Certified Advisor:
Company website: www.herantis.com
About
The shares of Herantis are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.
For more information, please visit www.herantis.com.
https://news.cision.com/herantis-pharma-oyj/r/composition-of-herantis-pharma-plc-s-shareholders--nomination-committee,c3655746
https://mb.cision.com/Main/18884/3655746/1644088.pdf
(c) 2022 Cision. All rights reserved., source